Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

FLEXERIL

CYCLOBENZAPRINE HYDROCHLORIDE

Standard Dose
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview FLEXERIL is listed in Drugs@FDA under application 017821 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CYCLOBENZAPRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JANSSEN RES AND DEV Submission history Latest submission status date: 2013-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLEXERIL is listed in Drugs@FDA under application 017821 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CYCLOBENZAPRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JANSSEN RES AND DEV Submission history Latest submission status date: 2013-04-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.